How Does This Inherited Mutation Differ from Common Lung Cancer Variants?
A rare inherited genetic mutation could help explain why some people who have never smoked still develop lung cancer, according to a new study published in Science. Researchers found that a small subset of non-smokers diagnosed with the disease carry a specific genetic alteration passed down through families. This discovery sheds light on a long-standing mystery in oncology, as smoking remains the leading cause of lung cancer but does not account for all cases. The study focused on individuals with no history of tobacco use who developed lung adenocarcinoma, the most common type of lung cancer in non-smokers.
The research team, co-led by Dr. Jaclyn Hechtman from Memorial Sloan Kettering Cancer Center, analyzed tumor samples and genetic data from patients with no smoking history. They identified a recurring mutation in a gene called EGFR that was not acquired during life but instead inherited. Unlike typical EGFR mutations seen in lung cancer, which develop spontaneously, this variant was present in every cell of the body, indicating a germline origin. The mutation appears to activate signaling pathways that promote uncontrolled cell growth in the lungs, even without exposure to carcinogens like tobacco smoke. Scientists believe this finding could redefine how lung cancer risk is assessed in individuals with a family history of the disease but no personal smoking history.
Could Genetic Screening Help Identify At-Risk Non-Smokers Early?
Unlike somatic EGFR mutations that arise randomly in lung tissue over time, this inherited form is present from birth and can be passed to offspring. It was found in multiple family members across generations, suggesting a clear hereditary pattern. Laboratory models showed that cells with this mutation exhibited increased proliferation and resistance to normal growth controls, mirroring cancerous behavior. The mutation’s location within the EGFR gene also differs from those typically targeted by existing therapies, raising questions about treatment effectiveness. Researchers emphasize that while rare, this genetic variant may represent a distinct subtype of lung cancer requiring tailored screening and intervention strategies.
Experts suggest that individuals with a strong family history of lung cancer, especially among non-smokers, might benefit from genetic counseling and testing for this specific mutation. Early detection through low-dose CT scans could improve outcomes if cancer develops. However, scientists caution that widespread screening is not yet recommended due to the mutation’s rarity and the need for further validation in larger, diverse populations. They also note that environmental factors or other unknown genes may still play a role in many non-smoker cases. The study opens the door to precision prevention approaches, where genetic insights guide personalized monitoring rather than relying solely on lifestyle factors.
Is this genetic mutation common among lung cancer patients? No, the inherited EGFR mutation identified in the study is rare and accounts for only a small fraction of lung cancer cases in non-smokers. Most cases still involve spontaneous mutations or other causes.
Frequently Asked Questions
Can this mutation be detected through a simple blood test? Yes, because it is present in all cells of the body, the mutation can be identified via germline genetic testing using blood or saliva samples, though such testing is not currently routine for lung cancer risk.
Should non-smokers with a family history of lung cancer get tested? Genetic testing may be considered for individuals with multiple close relatives affected by lung cancer, especially if they never smoked, but should be done under the guidance of a genetic counselor or oncologist.